Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenzhen Liang

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|November 22, 2024
Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10-60 years in ChinaZhenzhen Liang, Xu Chen, Bo Xing, et al.
International Journal of Molecular Medicine|November 24, 2012
Attenuation of exogenous angiotensin II stress-induced damage and apoptosis in human vascular endothelial cells via microRNA-155 expressionTe Liu, Dingzhu Shen, Sanli Xing, et al.
Frontiers in Immunology|November 25, 2022
Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3-9-month intervals following two-dose inactivated vaccine (CoronaVac)Yuting Liao, Yingping Chen, Bo Chen, et al.
Vaccine|August 5, 2020
Efficacy and safety of a live attenuated influenza vaccine in Chinese healthy children aged 3-17 years in one study center of a randomized, double-blind, placebo-controlled phase 3 clinical trial, 2016/17 seasonShenyu Wang, Yihong Zheng, Xiongyuan Jin, et al.
Vaccine|April 29, 2022
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label studyHuakun Lv, Shenyu Wang, Zhenzhen Liang, et al.
Genome Biology|January 5, 2021
Compacting a synthetic yeast chromosome armZhouqing Luo, Kang Yu, Shangqian Xie, et al.
Oxidative Medicine and Cellular Longevity|June 23, 2022
AdipoR1 Regulates Ionizing Radiation-Induced Ferroptosis in HCC cells through Nrf2/xCT PathwayHao Feng, Yi Liu, Yuhan Gan, et al.
Iscience|September 12, 2022
Synthetic refactor of essential genes decodes functionally constrained sequences in yeast genomeZhenzhen Liang, Zhouqing Luo, Weimin Zhang, et al.
Microbial Genomics|February 26, 2026
Full-genome analysis of emerging Coxsackievirus B4 genotype D strains associated with herpangina in eastern ChinaXiaosong Hu, Yuxiang Sun, Bo Xing, et al.
Gut Pathogens|November 4, 2025
Epidemiological, clinical, and molecular characteristics of coxsackievirus A2 infections during a herpangina outbreak in children on an Island in Eastern China in 2024: a surveillance-based studyBo Xing, Linjie Hu, Xiaosong Hu, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|November 22, 2024
Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10-60 years in ChinaZhenzhen Liang, Xu Chen, Bo Xing, et al.
International Journal of Molecular Medicine|November 24, 2012
Attenuation of exogenous angiotensin II stress-induced damage and apoptosis in human vascular endothelial cells via microRNA-155 expressionTe Liu, Dingzhu Shen, Sanli Xing, et al.
Frontiers in Immunology|November 25, 2022
Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3-9-month intervals following two-dose inactivated vaccine (CoronaVac)Yuting Liao, Yingping Chen, Bo Chen, et al.
Vaccine|August 5, 2020
Efficacy and safety of a live attenuated influenza vaccine in Chinese healthy children aged 3-17 years in one study center of a randomized, double-blind, placebo-controlled phase 3 clinical trial, 2016/17 seasonShenyu Wang, Yihong Zheng, Xiongyuan Jin, et al.
Vaccine|April 29, 2022
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label studyHuakun Lv, Shenyu Wang, Zhenzhen Liang, et al.
Genome Biology|January 5, 2021
Compacting a synthetic yeast chromosome armZhouqing Luo, Kang Yu, Shangqian Xie, et al.
Oxidative Medicine and Cellular Longevity|June 23, 2022
AdipoR1 Regulates Ionizing Radiation-Induced Ferroptosis in HCC cells through Nrf2/xCT PathwayHao Feng, Yi Liu, Yuhan Gan, et al.
Iscience|September 12, 2022
Synthetic refactor of essential genes decodes functionally constrained sequences in yeast genomeZhenzhen Liang, Zhouqing Luo, Weimin Zhang, et al.
Microbial Genomics|February 26, 2026
Full-genome analysis of emerging Coxsackievirus B4 genotype D strains associated with herpangina in eastern ChinaXiaosong Hu, Yuxiang Sun, Bo Xing, et al.
Gut Pathogens|November 4, 2025
Epidemiological, clinical, and molecular characteristics of coxsackievirus A2 infections during a herpangina outbreak in children on an Island in Eastern China in 2024: a surveillance-based studyBo Xing, Linjie Hu, Xiaosong Hu, et al.
Pageof 7